ReWalk Robotics Ltd (NASDAQ:LFWD) — Market Cap & Net Worth
Market Cap & Net Worth: ReWalk Robotics Ltd (LFWD)
ReWalk Robotics Ltd (NASDAQ:LFWD) has a market capitalization of $25.05 Million ($25.05 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #24312 globally and #5003 in its home market, demonstrating a -5.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ReWalk Robotics Ltd's stock price $7.25 by its total outstanding shares 3784698 (3.78 Million). Analyse LFWD cash flow metrics to see how efficiently the company converts income to cash.
ReWalk Robotics Ltd Market Cap History: 2015 to 2026
ReWalk Robotics Ltd's market capitalization history from 2015 to 2026. Data shows change from $9.58 Billion to $27.42 Million (-40.04% CAGR).
Index Memberships
ReWalk Robotics Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #703 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2325 of 3165 |
Weight: ReWalk Robotics Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ReWalk Robotics Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ReWalk Robotics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.10x
ReWalk Robotics Ltd's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.85 Billion | $5.87 Million | -$32.50 Million | 315.98x | N/A |
| 2017 | $728.55 Million | $7.75 Million | -$24.72 Million | 93.97x | N/A |
| 2018 | $115.24 Million | $6.54 Million | -$21.68 Million | 17.61x | N/A |
| 2019 | $57.22 Million | $4.87 Million | -$15.55 Million | 11.74x | N/A |
| 2020 | $34.97 Million | $4.39 Million | -$12.98 Million | 7.96x | N/A |
| 2021 | $32.59 Million | $5.97 Million | -$12.74 Million | 5.46x | N/A |
| 2022 | $20.13 Million | $5.51 Million | -$19.57 Million | 3.65x | N/A |
| 2023 | $20.61 Million | $13.85 Million | -$22.13 Million | 1.49x | N/A |
| 2024 | $6.70 Million | $25.66 Million | -$28.94 Million | 0.26x | N/A |
| 2025 | $2.18 Million | $22.03 Million | -$19.91 Million | 0.10x | N/A |
Competitor Companies of LFWD by Market Capitalization
Companies near ReWalk Robotics Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to ReWalk Robotics Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
ReWalk Robotics Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, ReWalk Robotics Ltd's market cap moved from $9.58 Billion to $ 27.42 Million, with a yearly change of -40.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $27.42 Million | +1155.63% |
| 2025 | $2.18 Million | -67.40% |
| 2024 | $6.70 Million | -67.50% |
| 2023 | $20.61 Million | +2.37% |
| 2022 | $20.13 Million | -38.21% |
| 2021 | $32.59 Million | -6.82% |
| 2020 | $34.97 Million | -38.89% |
| 2019 | $57.22 Million | -50.34% |
| 2018 | $115.24 Million | -84.18% |
| 2017 | $728.55 Million | -60.71% |
| 2016 | $1.85 Billion | -80.65% |
| 2015 | $9.58 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of ReWalk Robotics Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.05 Million USD |
| MoneyControl | $25.05 Million USD |
| MarketWatch | $25.05 Million USD |
| marketcap.company | $25.05 Million USD |
| Reuters | $25.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ReWalk Robotics Ltd
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal… Read more